Zenith Drugs Reports H1 FY27 Results with PAT Growth to ₹262.32 Lakh
Zenith Drugs Ltd · Outcome · 14 Nov 2026, 9:12 pm
Zenith Drugs Reports H1 FY27 Results with PAT Growth to ₹262.32 Lakh Zenith Drugs reported total revenue from operations of ₹8,150.27 lakh for the half-year ended 30th Sep'26, up 4.19% YoY from ₹7,822.35 lakh. Total income reached ₹8,426.02 lakh compared to ₹8,013.81 lakh in H1 FY26. Net profit rose 12.32% YoY to ₹262.32 lakh from ₹233.55 lakh, with basic and diluted EPS improving to ₹1.53 per share from ₹1.36. Total expenses stood at ₹8,163.70 lakh versus ₹7,758.72 lakh, driven by ₹6,837.15 lakh in material costs. Total assets increased to ₹19,683.55 lakh.
Original exchange filing (PDF)
More announcements from Zenith Drugs Ltd
- Zenith Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Zenith Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 14 Nov 2026
- Zenith Drugs Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Zenith Drugs Limited has informed the Exchange about securing a tender awarded Rajasthan Medical Services Corporation Limited. · 04 Nov 2026
- Zenith Drugs Limited has informed the Exchange about securing a tender awarded by Uttar Pradesh Medical Supplies Corporation Limited. · 30 Oct 2026
- Zenith Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on October 13, 2026. · 13 Oct 2026
- Zenith Drugs Limited has informed the Exchange about securing a tender awarded by Haryana Medical Services Corporation Limited. · 10 Oct 2026
